The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D06 | Antibiotics and chemotherapeutics for dermatological use | |
| 3 | D06A | Antibiotics for topical use | |
| 4 | D06AA | Tetracycline and derivatives |
| Code | Title | |
|---|---|---|
| D06AA01 | Demeclocycline | |
| D06AA02 | Chlortetracycline | |
| D06AA03 | Oxytetracycline | |
| D06AA04 | Tetracycline |
| Active Ingredient | Description | |
|---|---|---|
| Chlortetracycline |
Chlortetracycline is a tetracycline antibiotic isolated from Streptomyces aureofaciens. It has a role as an antiprotozoal drug, a fluorescent probe, a calcium ionophore and an antibacterial drug. |
|
| Demeclocycline |
Tetracyclines have a broad spectrum of anti-microbial activity and act by interfering with bacterial protein synthesis. They are active against a large number of gram positive and gram negative pathogenic bacteria, including some which are resistant to penicillin. |
|
| Oxytetracycline |
Oxytetracycline is a broad spectrum tetracycline antibiotic with activity against a large number of gram positive and gram negative bacteria. The product acts by interfering with bacterial protein synthesis. |
|
| Tetracycline |
Tetracyclines are taken up into sensitive bacterial cells by an active transport process. Once within the cell they bind reversibly to the 30S subunit of the ribosome, preventing the binding of aminoacyl transfer RNA and inhibiting protein synthesis and hence cell growth. |
